DSP Nifty Healthcare ETF
Direct · Growth ₹15.81
26 Oct 2026
NAV
9.3%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
0.47
Sharpe
-15.7%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.20%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.44 L | 9.1% | -10.1% | 35.3% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | Category avg |
|---|---|---|
| 1 Year | 9.1% | 10.7% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 9.3% | 10.4% | -4.6% | 23.8% | 0.47 | 0.99 | 94% | — | — |
-15.7%
Max Drawdown
2 mo
Drawdown Duration
5 mo
Recovery Time
-3.4%
Avg Drawdown
Calmar Ratio by Duration
0.59
1Y
20
Total Holdings
75.8%
Top 10 Weight
2
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 16.99% |
| 2 | Divi's Laboratories Limited | 10.43% |
| 3 | Apollo Hospitals Enterprise Limited | 7.42% |
| 4 | Laurus Labs Limited | 6.81% |
| 5 | Cipla Limited | 6.69% |
| 6 | Dr. Reddy's Laboratories Limited | 6.64% |
| 7 | Torrent Pharmaceuticals Limited | 6.24% |
| 8 | Max Healthcare Institute Limited | 6.11% |
| 9 | Lupin Limited | 4.36% |
| 10 | Aurobindo Pharma Limited | 4.08% |